DRUGS & SUPPLEMENTS

Polyethylene Glycol 3350

advertisement
What are the side effects you encounter while taking this medicine?

Polyethylene Glycol 3350 uses



One Gallon

For Gastrointestinal Lavage                                                                      Rx only

DESCRIPTION: Polyethylene Glycol 3350® with flavor packs is a colon lavage preparation provided as water-soluble components for solution. In solution this preparation with one flavor pack delivers the following, in grams per liter.

Polyethylene Glycol 3350 3350 60.00
Sodium chloride 1.46
Potassium chloride 0.745
Sodium bicarbonate 1.68
Sodium sulfate 5.68
Flavor ingredients 0.851

When dissolved in sufficient water to make 1 gallon, the final solution contains 125 mEq/L sodium, 10 mEq/L potassium, 20 mEq/L bicarbonate, 80 mEq/L sulfate, 35 mEq/L chloride and 18 mEq/L Polyethylene Glycol 3350 3350. The reconstituted solution is isosmotic and has a mildly salty taste. This preparation can be used without the flavor packs and is administered orally or via nasogastric tube.

Each orange flavor pack (3.22 g) contains hypromellose, natural and artifical orange powder, saccharin sodium, colloidal silicon dioxide. Each lemon lime flavor pack (3.22 g) contains, hypromellose, natural and artifical lemon lime powder, Prosweet® Powder Natural, saccharin sodium, colloidal silicon dioxide. Each cherry flavor pack (3.22 g) contains hypromellose, artifical cherry powder, saccharin sodium, colloidal silicon dioxide.

CLINICAL

Pharmacology: Polyethylene Glycol 3350® with flavor packs cleanses the bowel by induction of diarrhea. The osmotic activity of Polyethylene Glycol 3350 3350, in combination with the electrolyte concentration, results in virtually no net absorption or excretion of ions or water.

INDICATIONS AND USAGE: Polyethylene Glycol 3350 with flavor packs is indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination.

advertisement

CONTRAINDICATIONS:

Polyethylene Glycol 3350 is contraindicated in the following conditions:

  • Gastrointestinal (GI) obstruction
  • Bowel perforation
  • Gastric retention
  • Ileus
  • Toxic colitis or toxic megacolon
  • Known allergy or hypersensitivity to any component of Polyethylene Glycol 3350

WARNINGS: Flavor packs are for use only in combination with the contents of the accompanying 1 gallon container. No other additional ingredients (e.g., flavorings) should be added to the solution. Polyethylene Glycol 3350 with flavor packs should be used with caution in patients with severe ulcerative colitis.

PRECAUTIONS:

General: Patients with impaired gag reflex, unconscious or semiconscious patients and patients prone to regurgitation or aspiration should be observed during the administration of Polyethylene Glycol 3350® with flavor packs, especially if it is administered via nasogastric tube.

Serious Fluid and Serum Chemistry Abnormalities

Advise patients to hydrate adequately before, during, and after the use of Polyethylene Glycol 3350. Use caution in patients with congestive heart failure when replacing fluids. If a patient develops significant vomiting or signs of dehydration including signs of orthostatic hypotension after taking Polyethylene Glycol 3350, consider performing post-colonoscopy lab tests and treat accordingly. Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment. Fluid and electrolyte abnormalities should be corrected before treatment with Polyethylene Glycol 3350.

In addition, use caution when prescribing Polyethylene Glycol 3350 for patients who have conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmia, and renal impairment.

Cardiac Arrhythmias

There have been rare reports of serious arrhythmias associated with the use of ionic osmotic laxative products for bowel preparation. Use caution when prescribing Polyethylene Glycol 3350 for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Pre-dose and post-colonoscopy ECGs should be considered in patients at increased risk of serious cardiac arrhythmias.

Seizures

There have been reports of generalized tonic-clonic seizures and/or loss of consciousness associated with use of bowel preparation products in patients with no prior history of seizures. The seizures cases were associated with electrolyte abnormalities (e.g., hyponatremia, hypokalemia, hypocalcemia, and hypomagnesemia) and low serum osmolality. The neurologic abnormalities resolved with correction of fluid and electrolyte abnormalities.

Use caution with prescribing Polyethylene Glycol 3350 for patients with a history of seizures and in patients at increased risk of seizure, such as patients taking medications that lower the seizure threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected hyponatremia.

Renal Impairment

Use caution when prescribing Polyethylene Glycol 3350 for patients with impaired renal function or patients taking concomitant medications that may affect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs). Advise these patients of the importance of adequate hydration, and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients.

Colonic Mucosal Ulcerations and Ischemic Colitis

Administration of osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Concurrent use of stimulant laxatives and Polyethylene Glycol 3350 may increase the risk. The potential for mucosal ulcerations resulting from the bowel preparation should be considered when interpreting colonoscopy findings in patients with known or suspected inflammatory bowel disease (IBD).

Use in Patients with Significant Gastrointestinal Disease

If gastrointestinal obstruction or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering Polyethylene Glycol 3350. Use caution in patients with severe active ulcerative colitis.

Aspiration

Use with caution in patients with impaired gag reflex and patients prone to regurgitation or aspiration. Such patients should be observed during administration of Polyethylene Glycol 3350, especially if it is administered via nasogastric tube.

Not for Direct Ingestion

The contents of each jug must be diluted with water to final volume of 4 liters (4L) and ingestion of additional water is important to patient tolerance. Direct ingestion of the undissolved powder may increase the risk of nausea, vomiting, dehydration, and electrolyte disturbances.

  

If gastrointestinal obstruction or perforation is suspected appropriate studies should be performed to rule out these conditions before administration of Polyethylene Glycol 3350® with flavor packs.

Patient Counseling Information:

Polyethylene Glycol 3350® with flavor packs produces a watery stool which cleanses the bowel prior to examination.

For best results, no solid food should be ingested during the 3 - 4 hour period prior to the initiation of Polyethylene Glycol 3350 with flavor packs administration. In no case should solid foods be eaten within 2 hours of drinking Polyethylene Glycol 3350 with flavor packs.

The rate of administration is 240 mL (8 fl. oz.) every 10 minutes. Rapid drinking of each portion is preferred rather than drinking small amounts continuously.

The first bowel movement should occur approximately one hour after the start of Polyethylene Glycol 3350 with flavor packs administration.

Administration of Polyethylene Glycol 3350 with flavor packs should be continued until the watery stool is clear and free of solid matter. This normally requires the consumption of approximately 3-4 liters (3-4 quarts), although more or less may be required in some patients. The unused portion should be discarded.

Consume water or clear liquids during the bowel preparation and after completion of the bowel preparation up until 2 hours before the time of the colonoscopy.

Drug Interactions:

Drugs That May Increase Risks Due to Fluid and Electrolyte Abnormalities

Use caution when prescribing Polyethylene Glycol 3350 for patients with conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizures, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities. Consider additional patient evaluations as appropriate in patients taking these concomitant medications.

Potential for Altered Drug Absorption

Oral medication administered within one hour of the start of administration of Polyethylene Glycol 3350 may be flushed from the gastrointestinal tract and the medication may not be absorbed properly.

Carcinogenesis, Mutagenesis, Impairment of Fertility: Studies to evaluate carcinogenesis or mutagenic potential or potential to adversely affect male or female fertility have not been performed.

Pregnancy: Category C. Animal reproduction studies have not been conducted with Polyethylene Glycol 3350 to evaluate the carcinogenic potential. It is not known whether Polyethylene Glycol 3350 can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Polyethylene Glycol 3350 should be given to a pregnant woman only if clearly needed.

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Polyethylene Glycol 3350 is administered to a nursing woman.

Pediatric Use: The safety and effectiveness of Polyethylene Glycol 3350 in pediatric patients have not been established.

Geriatric Use: Published literature contains isolated reports of serious adverse reactions following the administration of PEG-ELS products in patients over 60 years of age. These adverse events include upper GI bleeding from Mallory-Weiss Tear, esophageal perforation, asystole, sudden dyspnea with pulmonary edema, and "butterfly-like" infiltrate on chest x-ray after vomiting and aspirating PEG.

ADVERSE REACTIONS: Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in clinical studies of another drug and may not reflect the rates observed in practice.

Nausea, abdominal fullness and bloating are the most common adverse reactions (occurring in up to 50% of patients) to administration of Polyethylene Glycol 3350. Abdominal cramps, vomiting and anal irritation occur less frequently. These adverse reactions are transient and usually subside rapidly. Isolated cases of urticaria, rhinorrhea, dermatitis, and rarely anaphylaxis, angioedema, tongue edema, and face edema have been reported which may represent allergic reactions.

To report suspected adverse events contact Meda Pharmaceuticals Inc. at toll free 1-888-317-0001 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DOSAGE AND ADMINISTRATION: Polyethylene Glycol 3350 with flavor packs can be administered orally or by nasogastric tube. Patients should fast at least 3 hours prior to administration. A one hour waiting period after the appearance of clear liquid stool should be allowed prior to examination to complete bowel evacuation. No foods except clear liquids should be permitted prior to examination after Polyethylene Glycol 3350 with flavor packs administration.

Oral: The recommended adult oral dose is 240 mL (8 fl. oz.) every 10 minutes (see PRECAUTIONS, Information for Patients ). Lavage is complete when fecal discharge is clear. Lavage is usually complete after the ingestion of 3-4 liters (3-4 quarts).

Nasogastric Tube: Polyethylene Glycol 3350 with flavor packs is administered at a rate of 20-30 mL per minute (1.2-1.8 L/hour).

Preparation of Polyethylene Glycol 3350 with flavor packs Solution:

This preparation can be used with or without flavor packs.

  • To add flavor, tear open one flavor pack at the indicated marking and pour contents into the bottle BEFORE reconstitution. Discard unused flavor packs.
  • SHAKE WELL to incorporate flavoring into powder.
  • Add tap water to FILL line. Replace cap tightly and mix or shake well until all ingredients have dissolved. (No other additional ingredients, e.g. flavorings, should be added to the solution.)

Note: If not using flavor packs, omit steps one and two above.

HOW SUPPLIED: Polyethylene Glycol 3350 with flavor packs is supplied in 1 gallon bottles with an attached package containing flavor packs. Each 1 gallon bottle contains Polyethylene Glycol 3350 3350 227.10 g, sodium chloride 5.53 g, potassium chloride 2.82 g, sodium bicarbonate 6.36 g, sodium sulfate (anhydrous) 21.50 g. Each preparation is supplied in powdered form, for oral administration as a solution.

Polyethylene Glycol 3350 with flavor packs         1 gallon               NDC 68220-133-01

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F).

KEEP RECONSTITUTED SOLUTION REFRIGERATED. USE WITHIN 48 HOURS.

DISCARD UNUSED PORTION.

Rx only

Manufactured for:

Meda Pharmaceuticals Inc.

Somerset, NJ, USA

Manufactured by:  Kremers Urban Pharmaceuticals Inc., Seymour, IN 47274

For Medical Inquiries,

Call toll-free 1-888-317-0001

NDC 68220-133-01

REV 08/ 2013

advertisement

Medication Guide

Colyte® (co-light) with Flavor Packs

(peg-3350 & electrolytes for oral solution)

Read this Medication Guide before you start taking Polyethylene Glycol 3350. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.

What is the most important information I should know about Polyethylene Glycol 3350?

Polyethylene Glycol 3350 can cause serious side effect, including:

Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood. These changes can cause:

  • abnormal heartbeats that can cause death
  • seizures. This can happen even if you have never had a seizure.
  • kidney problems

Your risk of having fluid loss and changes in body salts with Polyethylene Glycol 3350 is higher if you:

  • have heart problems
  • have kidney problems
  • take water pills (diuretics) or non-steroidal anti-inflammatory drugs (NSAIDS)

Tell your healthcare provider right away if you have any of these symptoms of a loss of too much body fluid (dehydration) while taking Polyethylene Glycol 3350:

  • vomiting
  • dizziness
  • urinating less often than normal
  • headache

See “What are the possible side effects of Polyethylene Glycol 3350?” for more information about side effects.

What is Polyethylene Glycol 3350?

Polyethylene Glycol 3350 is a prescription medicine used to clean the colon before a colonoscopy or barium enema X-ray examination. Polyethylene Glycol 3350 cleans your colon by causing you to have diarrhea. Cleaning your colon helps your healthcare provider see the inside of your colon more clearly during your colonoscopy or barium enema X-ray examination.

It is not known if Polyethylene Glycol 3350 is safe and effective in children.

Who should not take Polyethylene Glycol 3350?

Do not take Polyethylene Glycol 3350 if your healthcare provider has told you that you have:

  • a blockage in your intestine (bowel obstruction)
  • an opening in the wall of your stomach or intestine (bowel perforation)
  • problems with food and fluid emptying from your stomach (gastric retention)
  • a very dilated intestine (toxic megacolon)
  • an allergy to any of the ingredients in Polyethylene Glycol 3350. See the end of this leaflet for a complete list of ingredients in Polyethylene Glycol 3350.

What should I tell my healthcare provider before taking Polyethylene Glycol 3350?

Before you take Polyethylene Glycol 3350, tell your healthcare provider if you:

  • have heart problems
  • have a history of seizures
  • have kidney problems
  • have ulcerative colitis
  • have stomach or bowel problems
  • have problems with swallowing or gastric reflux
  • are withdrawing from drinking alcohol
  • have a low blood salt (sodium) level
  • have any other medical conditions
  • are pregnant or plan to become pregnant. It is not known if Polyethylene Glycol 3350 will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Polyethylene Glycol 3350 passes into your breast milk. You and your healthcare provider should decide if you will take Polyethylene Glycol 3350 while breastfeeding.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Polyethylene Glycol 3350 may affect how other medicines work. Medicines taken by mouth may not be absorbed properly when taken within 1 hour before the start of Polyethylene Glycol 3350.

Especially tell you healthcare provider if you take:

  • medicines for blood pressure or heart problems
  • medicines for kidney problems
  • medicines for seizures
  • water pills (diuretics)
  • non-steroidal anti-inflammatory medicines (NSAID) pain medicines
  • laxatives

Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure if you are taking any of the medicines listed above

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take Polyethylene Glycol 3350?

See the Instructions for Use at the end of this Medication Guide for dosing instructions. You must read, understand, and follow these instructions to take Polyethylene Glycol 3350 the right way.

  • Take Polyethylene Glycol 3350 exactly as your healthcare provider tells you to take it.
  • The powder in the Polyethylene Glycol 3350 container must be mixed with water (diluted) before drinking. Do not take Polyethylene Glycol 3350 that has not been mixed with water, it may increase your risk of nausea, vomiting and fluid loss (dehydration).
  • Do not eat any solid foods 3 hours before you start taking Polyethylene Glycol 3350, while taking Polyethylene Glycol 3350, and 2 hours after taking Polyethylene Glycol 3350.
  • Drink clear liquids before you start taking Polyethylene Glycol 3350, while you take Polyethylene Glycol 3350 and after you finish taking Polyethylene Glycol 3350 to help prevent fluid loss (dehydration). Examples of clear liquids are:
    • water
    • clear fruit juices without pulp including apple, white grape, or white cranberry
    • strained limeade or lemonade
    • coffee or tea (Do not use any dairy or non-dairy creamer)
    • clear broth
    • clear soda
    • gelatin (without added fruit or topping)
    • popsicles without pieces of fruit or fruit pulp

    Do not eat or drink anything colored red or purple.

  • Do not eat or drink anything 2 hours before your colonoscopy or barium enema X-ray examination.
  • You should have your first bowel movement about 1 hour after you start taking Polyethylene Glycol 3350. Continue to take Polyethylene Glycol 3350 according to the Instructions for Use until your stool is clear, watery, and has no solid material in it.
  • Do not take other laxatives while taking Polyethylene Glycol 3350.
  • Stop drinking Polyethylene Glycol 3350 solution temporarily or allow for longer time between each dose if you have stomach discomfort, pain or bloating until your symptoms improve. If symptoms continue, tell your healthcare provider.

What are the possible side effects of Polyethylene Glycol 3350?

Polyethylene Glycol 3350 can cause serious side effects, including:

  • See “What is the most important information I should know about Polyethylene Glycol 3350?”
  • changes in certain blood tests. Your healthcare provider may do blood tests after you take Polyethylene Glycol 3350 to check your blood for changes. Tell your healthcare provider if you have any symptoms of too much fluid loss, including:
    • vomiting
    • nausea
    • bloating
    • dizziness
    • stomach-area (abdomen) cramping
    • headache
    • urinate less than usual
    • trouble drinking clear liquid
  • ulcers of the bowel or bowel problems (ischemic colitis). Tell your healthcare provider right away if you have severe stomach-area (abdomen) pain or rectal bleeding.

The most common side effects of Polyethylene Glycol 3350 include:

  • nausea
  • stomach-area (abdomen) fullness and bloating

Tell your healthcare provider if you have any side effect that bothers you or does not go away.

These are not all the possible side effects of Polyethylene Glycol 3350. For more information, ask you healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Polyethylene Glycol 3350?

  • Store Polyethylene Glycol 3350 at 68°F to 77°F (20°C to 25°C).
  • Store Polyethylene Glycol 3350 that has been mixed with water in the refrigerator.
  • Use Polyethylene Glycol 3350 within 48 hours after mixing with water. Safely throw away any Polyethylene Glycol 3350 that you do not use.

Keep Polyethylene Glycol 3350 and all medicines out of the reach of children.

General information about the safe and effective use of Polyethylene Glycol 3350.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Polyethylene Glycol 3350 for a condition for which it was not prescribed. Do not give Polyethylene Glycol 3350 to other people, even if they are going to have the same procedure you are. It may harm them.

This Medication Guide summarizes the most important information about Polyethylene Glycol 3350. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about Polyethylene Glycol 3350 that is written for health professionals.

For more information about Polyethylene Glycol 3350, call 1-888-317-0001.

What are the ingredients in Polyethylene Glycol 3350?

Active ingredients: Polyethylene Glycol 3350 (PEG) 3350, sodium chloride, potassium chloride, sodium bicarbonate, sodium sulfate

Inactive ingredients: Flavor pack ingredients:

Orange flavor pack:hypromellose, natural and artificial orange powder, saccharin sodium, colloidal silicon dioxide

Lemon lime flavor pack: hypromellose, natural and artificial lemon lime powder, Prosweet® Powder Natural, saccharin sodium, colloidal silicon dioxide

Cherry flavor pack: hypromellose, artificial cherry powder, saccharin sodium, colloidal silicon dioxide

Issued: August/2013

advertisement

Instructions for Use

Polyethylene Glycol 3350®(co-light) with Flavor Packs

(peg-3350 & electrolytes for oral solution)

Read this Instructions for Use before you start taking Polyethylene Glycol 3350. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.

How should I take Polyethylene Glycol 3350?

Polyethylene Glycol 3350 can be taken with or without a flavor pack. If you use a flavor pack, complete Steps 1 through 8. If you do not use a flavor pack, throw away the flavor packs and complete Steps 4 through 8.

Step 1:  Remove the cap from the Polyethylene Glycol 3350 bottle.

Step 2:  Tear open 1 flavor pack of your choice and pour contents into the Polyethylene Glycol 3350 bottle. Throw away the unused flavor packs.

Step 3:  Replace the cap on the Polyethylene Glycol 3350 bottle. Shake the Polyethylene Glycol 3350 bottle well to mix the contents of the flavor pack into the powder.

Step 4:  Remove the cap from the Polyethylene Glycol 3350 bottle. Add water to the top of the line on the Polyethylene Glycol 3350 bottle marked “FILL TO TOP OF LINE ONE GALLON”.

Step 5:  Replace the cap on the Polyethylene Glycol 3350 bottle tightly and shake the Polyethylene Glycol 3350 bottle well to dissolve the powder. No other ingredients should be added to the Polyethylene Glycol 3350 bottle.

Step 6:  Refrigerate the Polyethylene Glycol 3350 solution until you are ready to drink it. The Polyethylene Glycol 3350 solution should be used within 48 hours after mixing.

Step 7:  Drink one 8 ounce glass of Polyethylene Glycol 3350 solution every 10 minutes. It is best to drink each glass of Polyethylene Glycol 3350 solution quickly, instead of sipping it slowly. Continue drinking one 8 ounce glass of Polyethylene Glycol 3350 solution every 10 minutes until your stool is clear, watery, and has no solid material in it. This normally requires drinking 3 to 4 liters of Polyethylene Glycol 3350 solution to clean your colon. The Polyethylene Glycol 3350 bottle should be empty or have less than 1 liter of Polyethylene Glycol 3350 solution remaining when your colon cleaning is completed.

Step 8:  Safely throw away any Polyethylene Glycol 3350 solution that you do not use.

This Medication Guide and Instructions for Use have been approved by the U.S. Food and Drug Administration.

Manufactured for:

Meda Pharmaceuticals Inc., Somerset, NJ, USA

Manufactured by: Kremers Urban Pharmaceuticals Inc., Seymour, In 47274, USA

For Medical Inquiries, Call toll-free 1-888-317-0001

Revised 08/2013

NDC 68220-133-01                     Note to Pharmacist:

                                                      DISPENSE ENCLOSED MEDICATION GUIDE.

                                                      Dispense bottle and all attached flavor packs to patient.

Polyethylene Glycol 3350®

with

Flavor Packs

(peg-3350 & electrolytes for oral solution)

Rx Only

4011310 Rev. 08/2013 133-0310-01

Contents make 1 Gallon (3.785 Liters) of solution

This package contains the following ingredients:

Polyethylene Glycol 3350 3350 227.10 grams
Sodium chloride 5.53 grams
Potassium chloride 2.82 grams
Sodium bicarbonate 6.36 grams
Sodium sulfate (anhydrous) 21.50 grams

When dissolved in sufficient water to make 1 gallon, the final solution contains

125 mEq/L sodium, 10 mEq/L potassium, 20 mEq/L bicarbonate, 80 mEq/L

sulfate, 35 mEq/L chloride and 18 mEq/L Polyethylene Glycol 3350 3350.

Store powder at 20° to 25°C (68° to 77°F); excursions permitted between

15° to 30°C (59° to 86°F).

KEEP RECONSTITUTED SOLUTION REFRIGERATED.

USE WITHIN 48 HOURS. DISCARD UNUSED PORTION.

APPROXIMATE NET WEIGHT: 263 GRAMS

Filled by net weight, product may settle.

MEDA

PHARMACEUTICALS®

1 gallon (3.785 liters)

Attention Pharmacist: Dispense all

attached flavor packs to the patient.

orange

flavor pack

FOR USE ONLY IN COMBINATION WITH

THE ACCOMPANYING CONTAINER.

net wt. 3.22 g

Attention Pharmacist: Dispense all

attached flavor packs to the patient.

lemon lime

flavor pack

FOR USE ONLY IN COMBINATION WITH

THE ACCOMPANYING CONTAINER.

net wt. 3.22 g

Attention Pharmacist: Dispense all

attached flavor packs to the patient.

cherry

flavor pack

FOR USE ONLY IN COMBINATION WITH

THE ACCOMPANYING CONTAINER.

net wt. 3.22 g

advertisement

Polyethylene Glycol 3350 pharmaceutical active ingredients containing related brand and generic drugs:

infoActive ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.


Polyethylene Glycol 3350 available forms, composition, doses:

infoForm of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.


Polyethylene Glycol 3350 destination | category:

infoDestination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.


Polyethylene Glycol 3350 Anatomical Therapeutic Chemical codes:

infoA medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.


Polyethylene Glycol 3350 pharmaceutical companies:

infoPharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.


advertisement

References

  1. Dailymed."PURELAX (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [CVS PHARMACY]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Polyethylene Glycol 3350?

Depending on the reaction of the Polyethylene Glycol 3350 after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Polyethylene Glycol 3350 not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Polyethylene Glycol 3350 addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

advertisement

Review

sDrugs.com conducted a study on Polyethylene Glycol 3350, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Polyethylene Glycol 3350 consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reports

One visitor reported age

Visitors%
1-51
100.0%

Visitor reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 14 here

The information was verified by Dr. Arunabha Ray, MD Pharmacology

© 2002 - 2018 "sDrugs.com". All Rights Reserved